Seeing Is Believing
ENLV is currently covered by 1 analysts with an average price target of $7.23. This is a potential upside of $5.68 (366.45%) from yesterday's end of day stock price of $1.55.
Enlivex Therapeutics Ltd's activity chart (see below) currently has 0 price targets and 7 ratings on display. The stock rating distribution of ENLV is 100% BUY.
Highest price target for ENLV is $7, Lowest price target is $7, average price target is $7.23.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 23-Apr-2024. First documented stock forecast 02-May-2022.
Currently out of the existing stock ratings of ENLV, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$5.45 (351.61%)
7
16 days ago
0/2 (0%)
$5.68 (430.30%)
What is ENLV (Enlivex Therapeutics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most bullish on ENLV (Enlivex Therapeutics Ltd)?